Cyclosporine

CAS 59865-13-3 13 current records 3 historicalProtein

Who holds supplier records for Cyclosporine? 13 organisations hold a current record for Cyclosporine: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), India (2), Netherlands (1), United States (1) and 4 other countries (4).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cyclosporine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cyclosporine

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Cyclosporine expires 1 Apr 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cyclosporine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cyclosporine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Cyclosporine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
JIANGSU JOYANG LABORATORIES CO. LTD. YanchengCN
CEP 2003-105 - Rev 04
Ciclosporin
Jul 2026Inspected Nov 2024
Germany
TAPI CZECH INDUSTRIES S.R.O. OpavaCZ
CEP 2002-152 - Rev 07
Ciclosporin
Mar 2025Inspected Oct 2024
Czechia
North China Pharmaceutical Huasheng Co., Ltd. ShijiazhuangCN
CEP 2021-399 - Rev 00
Ciclosporin
Feb 2024Inspected Jun 2024
Netherlands
Zhejiang Ruibang Laboratories WenzhouCN
R0-CEP 2020-144 - Rev 00
Ciclosporin
Apr 2023—
CONCORD BIOTECH LIMITED AhmedabadIN
R1-CEP 2010-214 - Rev 03
Ciclosporin
Oct 2022—
CURIA ITALY S.R.L. Rozzano, MilanoIT
R1-CEP 1999-034 - Rev 06
Ciclosporin
Aug 2021—
CKD BIO CORPORATION Ansan-siKR
R1-CEP 2007-251 - Rev 02
Ciclosporin
Aug 2021—
AbbVie Inc. North ChicagoUS
R1-CEP 1998-093 - Rev 07
Ciclosporin
Oct 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Cyclosporine are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • WATSON LABORATORIES INC
    Inactive DMF 15328 · filed Mar 2001
  • NORTH CHINA PHARMACEUTICAL CORP
    Inactive DMF 14315, 10281 · filed Jul 1998
  • GALENA AS
    Inactive DMF 11971 · filed May 1996

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (43 listed products contain Cyclosporine). The latest listed patent expires 1 Apr 2042. The latest listed exclusivity runs to 23 Jun 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Cyclosporine is a protein active pharmaceutical ingredient (ChEMBL CHEMBL160).

Chemical identity

IUPAC name
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Canonical SMILES
CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
InChIKey
PMATZTZNYRCHOR-CGLBZJNRSA-N
Synonyms
27-400, ANTIBIOTIC S-7481F1, Atopica, Capimune, Capsorin, Cequa, Ciclosporin, Ciclosporin a, Ciclosporina, Ciclosporine, Ciclosporinum, Cyclosporin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Calcineurin Inhibitor Immunosuppressant
Mechanism of action
Calcineurin Inhibitors; Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cyclosporine?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Cyclosporine: TAPI NL BV (Netherlands), Abbvie Inc. (United States), CKD BIO CORP (South), CONCORD BIOTECH LTD (India), CURIA ITALY SRL (Italy), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (China), ZHEJIANG RUIBANG LABORATORIES INC (China) and Apotex Inc. (Canada), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cyclosporine Drug Master Files are active?

TAPI NL BV (DMF 13799, 12932), Abbvie Inc. (DMF 13800), CKD BIO CORP (DMF 12214), CONCORD BIOTECH LTD (DMF 23962), CURIA ITALY SRL (DMF 12949), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (DMF 33946), ZHEJIANG RUIBANG LABORATORIES INC (DMF 13858, 28512) and Apotex Inc. (DMF 13929) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cyclosporine records mean?

3 organisations have only inactive Type II DMFs for Cyclosporine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cyclosporine have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Cyclosporine on the EDQM register, including JIANGSU JOYANG LABORATORIES CO. LTD. Yancheng (CN), TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang (CN), Zhejiang Ruibang Laboratories Wenzhou (CN), CONCORD BIOTECH LIMITED Ahmedabad (IN) and CURIA ITALY S.R.L. Rozzano, Milano (IT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Cyclosporine?

Yes. The latest patent listed for an approved US product containing Cyclosporine expires 1 Apr 2042, across 43 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Cyclosporine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cyclosporine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.